Michael J. Boucher

Michael J. Boucher

Auto-generated profile, based on publicly available information

Michael J. Boucher

Stanford University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2018 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MBMichael J Boucher
Michael J Boucher
SGSreejoyee Ghosh
Sreejoyee Ghosh
LZLichao Zhang
Lichao Zhang
ALAvantika Lal
Avantika Lal
SJSe Won Jang
Se Won Jang
EYEllen Yeh
Ellen Yeh
Malaria parasites (Plasmodium spp.) and related apicomplexan pathogens contain a nonphotosynthetic plastid called the apicoplast. Derived from an unusual secondary eukaryote–eukaryote endosymbiosis, the apicoplast is a fascinating organelle whose function and biogenesis rely on a complex amalgamation of bacterial and algal pathways. Because these pathways are distinct from the human host, the apicoplast is an excellent source of novel antimalarial targets. Despite its biomedical importance and evolutionary significance, the absence of a reliable apicoplast proteome has limited most studies to the handful of pathways identified by homology to bacteria or primary chloroplasts, precluding our ability to study the most novel apicoplast pathways. Here, we combine proximity biotinylation-based proteomics (BioID) and a new machine learning algorithm to generate a high-confidence apicoplast proteome consisting of 346 proteins. Critically, the high accuracy of this proteome significantly outperforms previous prediction-based methods and extends beyond other BioID studies of unique parasite compartments. Half of identified proteins have unknown function, and 77% are predicted to be important for normal blood-stage growth. We validate the apicoplast localization of a subset of novel proteins and show that an ATP-binding cassette protein ABCF1 is essential for blood-stage survival and plays a previously unknown role in apicoplast biogenesis. These findings indicate critical organellar functions for newly discovered apicoplast proteins. The apicoplast proteome will be an important resource for elucidating unique pathways derived from secondary endosymbiosis and prioritizing antimalarial drug targets. Plasmodium parasites, which cause malaria, and related pathogens belonging to the phylum Apicomplexa contain a relict chloroplast called the apicoplast. During evolution, the apicoplast lost photosynthetic functions but retained critical metabolic pathways that are required for host cell infection. Because of its importance for parasite survival and its unusual evolutionary origin, the apicoplast is of major interest for its unique biology and its potential to yield new antimalarial drug targets. However, an accurate inventory of proteins that localize to the apicoplast is lacking, hindering our ability to study the most novel and biologically interesting aspects of apicoplast biology. To address this limitation, we combine proximity biotinylation-based proteomics and a new machine learning algorithm to identify apicoplast proteins in an accurate and unbiased manner. We identify 346 candidate apicoplast proteins with high confidence and find that many of these proteins are new and expected to be important for parasite survival. This proteomic resource will therefore be a valuable tool for elucidating the unique cell biology of the apicoplast and for identifying new antimalarial drug targets.

27 February 2019 in mSphere
Verified
Journal Article
Open access
MBMichael J. Boucher
Michael J. Boucher
EYEllen Yeh
Ellen Yeh
Malaria is a major cause of global childhood mortality. To sustain progress in disease control made in the last decade, new antimalarial therapies are needed to combat emerging drug resistance. Malaria parasites contain a relict chloroplast called the apicoplast, which harbors new targets for drug discovery. Unfortunately, some drugs targeting apicoplast pathways exhibit a delayed-death phenotype, which results in a slow onset-of-action that precludes their use as fast-acting, frontline therapies. Identification of druggable apicoplast biogenesis factors that will avoid the delayed-death phenotype is an important priority. Here, we find that chemical stabilization of an apicoplast-targeted mDHFR domain disrupts apicoplast biogenesis and inhibits parasite growth after a single lytic cycle, suggesting a non-delayed-death target. Our finding indicates that further interrogation of the mechanism-of-action of this exogenous fusion protein may reveal novel therapeutic avenues.

13 June 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MBMichael J Boucher
Michael J Boucher
EYEllen Yeh
Ellen Yeh
The apicoplast is a nonphotosynthetic plastid found in most apicomplexan parasites, including Plasmodium spp. (causative agents of malaria) and Toxoplasma gondii (causative agent of toxoplasmosis) [1, 2]. It houses essential metabolic pathways and is the target of several antiparasitic drugs [3]. A peculiar feature of the apicoplast is that, unlike endosymbiotic organelles in model organisms, it is integrated into the endomembrane system. Here, we discuss the interplay between the apicoplast and molecular machinery typically associated with the endomembrane system, highlighting outstanding questions and opportunities for drug discovery.

7 May 2020 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
JMJonathan C. Miller
Jonathan C. Miller
SDStephanie B. Delzell
Stephanie B. Delzell
JCJeniffer Concepción-Acevedo
Jeniffer Concepción-Acevedo
MBMichael J. Boucher
Michael J. Boucher
MKMichele Klingbeil
Michele Klingbeil
Mitochondrial DNA of Trypanosoma brucei and related parasites is a catenated network containing thousands of minicircles and tens of maxicircles, called kinetoplast DNA (kDNA). Replication of a single nucleoid requires at least three DNA polymerase I-like proteins (i.e. POLIB, POLIC and POLID), each showing discrete localizations near the kDNA during S phase. POLIB and POLID have roles in minicircle replication but the specific role of POLIC in kDNA maintenance is less clear. Here, we use an RNA interference (RNAi)-complementation system to dissect the functions of two distinct POLIC regions, i.e. the conserved family A DNA polymerase (POLA) domain and the uncharacterized N-terminal region (UCR). While RNAi complementation with wild-type POLIC restored kDNA content and cell cycle localization of kDNA, active site point mutations in the POLA domain impaired minicircle replication similar to that of POLIB and POLID depletions. Complementation with POLA domain alone abolished the formation of POLIC foci and partially rescued the RNAi phenotype. Furthermore, we provide evidence that the UCR is crucial in cell cycle-dependent protein localization and facilitates proper distribution of progeny networks. This is the first report of a DNA polymerase that impacts on mitochondrial nucleoid distribution. This article has an associated First Person interview with the first author of the paper.

14 February 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
MBMichael J. Boucher
Michael J. Boucher
SGSreejoyee Ghosh
Sreejoyee Ghosh
LZLichao Zhang
Lichao Zhang
ALAvantika Lal
Avantika Lal
SJSe Won Jang
Se Won Jang
EYEllen Yeh
Ellen Yeh
Malaria parasites (Plasmodium spp.) and related apicomplexan pathogens contain a non-photosynthetic plastid called the apicoplast. Derived from an unusual secondary eukaryote-eukaryote endosymbiosis, the apicoplast is a fascinating organelle whose function and biogenesis rely on a complex amalgamation of bacterial and algal pathways. Because these pathways are distinct from the human host, the apicoplast is an excellent source of novel antimalarial targets. Despite its biomedical importance and evolutionary significance, the absence of a reliable apicoplast proteome has limited most studies to the handful of pathways identified by homology to bacteria or primary chloroplasts, precluding our ability to study the most novel apicoplast pathways. Here we combine proximity biotinylation-based proteomics (BioID) and a new machine learning algorithm to generate a high-confidence apicoplast proteome consisting of 346 proteins. Critically, the high accuracy of this proteome significantly outperforms previous prediction-based methods and extends beyond other BioID studies of unique parasite compartments. Half of identified proteins have unknown function, and 77% are predicted to be important for normal blood-stage growth. We validate the apicoplast localization of a subset of novel proteins and show that an ATP-binding cassette protein ABCF1 is essential for blood-stage survival and plays a previously unknown role in apicoplast biogenesis. These findings indicate critical organellar functions for newly discovered apicoplast proteins. The apicoplast proteome will be an important resource for elucidating unique pathways derived from secondary endosymbiosis and prioritizing antimalarial drug targets.

1 November 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
EYEuna Yoo
Euna Yoo
CSChristopher J. Schulze
Christopher J. Schulze
BSBarbara H. Stokes
Barbara H. Stokes
OOOuma Onguka
Ouma Onguka
TYTomas Yeo
Tomas Yeo
MBMatthew Bogyo
Matthew Bogyo
SUMMARY: Salinipostin A (Sal A) is a potent antimalarial marine natural product with an undefined mechanism of action. Using a Sal A-derived activity-based probe, we identify its targets in the Plasmodium falciparum parasite. All of the identified proteins contain α/β serine hydrolase domains, and several are essential for parasite growth. One of the essential targets displays high homology to human monoacylglycerol lipase (MAGL) and is able to process lipid esters including a MAGL acylglyceride substrate. This Sal A target is inhibited by the anti-obesity drug Orlistat, which disrupts lipid metabolism and produces disorganized and stalled schizonts similar to Sal A. Resistance selections yielded parasites that showed only minor reductions in sensitivity and that acquired mutations in a protein linked to drug resistance in Toxoplasma gondii . This inability to evolve efficient resistance mechanisms combined with the non-essentiality of human homologs makes the serine hydrolases identified here promising antimalarial targets.